MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups
Authors
Keywords
-
Journal
DIGESTIVE DISEASES AND SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-18
DOI
10.1007/s10620-022-07508-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
- (2021) Seong Hee Kang et al. Clinical and Molecular Hepatology
- MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach
- (2021) Tsubasa Tsutsumi et al. HEPATOLOGY RESEARCH
- MAFLD: Renovation of clinical practice and disease awareness of fatty liver
- (2021) Takumi Kawaguchi et al. HEPATOLOGY RESEARCH
- NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?—Results From NHANES III
- (2021) Qi Huang et al. Frontiers in Medicine
- Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD
- (2021) Vy H. Nguyen et al. Clinical Gastroenterology and Hepatology
- Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease
- (2021) Joon Ho Moon et al. Gut and Liver
- Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan
- (2021) Masato Yoneda et al. JOURNAL OF GASTROENTEROLOGY
- MAFLD Enhances Clinical Practice for Liver Disease in the Asia-Pacific region
- (2021) Takumi Kawaguchi et al. Clinical and Molecular Hepatology
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk
- (2020) Eugene Han et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Comparison of MAFLD and NAFLD diagnostic criteria in real world
- (2020) Su Lin et al. LIVER INTERNATIONAL
- MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
- (2020) Sakura Yamamura et al. LIVER INTERNATIONAL
- Redefining fatty liver disease: an international patient perspective
- (2020) Gamal Shiha et al. Lancet Gastroenterology & Hepatology
- Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study
- (2020) Hokyou Lee et al. Clinical Gastroenterology and Hepatology
- Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease
- (2020) Vincent Wai-Sun Wong et al. Clinical Gastroenterology and Hepatology
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2019) Scott M. Grundy et al. CIRCULATION
- Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality
- (2019) Yoosoo Chang et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study
- (2018) Yoosoo Chang et al. GUT
- Obesity and cardiovascular disease: revisiting an old relationship
- (2018) Chrysi Koliaki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups
- (2017) Shiv Chitturi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment
- (2017) Vincent Wai-Sun Wong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- New trends on obesity and NAFLD in Asia
- (2017) Jian-Gao Fan et al. JOURNAL OF HEPATOLOGY
- Worldwide Exposures to Cardiovascular Risk Factors and Associated Health Effects
- (2016) Ioanna Tzoulaki et al. CIRCULATION
- Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011)
- (2016) Yong-ho Lee et al. HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- CAD-RADSTM Coronary Artery Disease – Reporting and Data System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology
- (2016) Ricardo C. Cury et al. Journal of Cardiovascular Computed Tomography
- Association of Random Plasma Glucose Levels With the Risk for Cardiovascular Disease Among Chinese Adults Without Known Diabetes
- (2016) Fiona Bragg et al. JAMA Cardiology
- Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study
- (2015) Vincent Wai-Sun Wong et al. HEPATOLOGY
- Non–Laboratory-Based Self-Assessment Screening Score for Non-Alcoholic Fatty Liver Disease: Development, Validation and Comparison with Other Scores
- (2014) Yong-ho Lee et al. PLoS One
- The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis
- (2013) Gitanjali M. Singh et al. PLoS One
- Obesity and Metabolic Syndrome in Korea
- (2012) Sang Woo Oh Diabetes & Metabolism Journal
- Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease
- (2011) V. W.-S. Wong et al. GUT
- Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes
- (2010) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 Expert Consensus Document on Coronary Computed Tomographic Angiography
- (2010) Daniel B. Mark et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
- (2009) Jeong-Hoon Lee et al. DIGESTIVE AND LIVER DISEASE
- Prevalence of obesity and metabolic syndrome in Korean adults
- (2007) H. S. Park et al. Obesity Reviews
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started